Cargando…

Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas

Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent...

Descripción completa

Detalles Bibliográficos
Autores principales: Heino, Sarika, Fang, Shentong, Lähde, Marianne, Högström, Jenny, Nassiri, Sina, Campbell, Andrew, Flanagan, Dustin, Raven, Alexander, Hodder, Michael, Nasreddin, Nadia, Xue, Hai-Hui, Delorenzi, Mauro, Leedham, Simon, Petrova, Tatiana V., Sansom, Owen, Alitalo, Kari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598008/
https://www.ncbi.nlm.nih.gov/pubmed/34788095
http://dx.doi.org/10.1126/sciadv.abj0512
_version_ 1784600718143913984
author Heino, Sarika
Fang, Shentong
Lähde, Marianne
Högström, Jenny
Nassiri, Sina
Campbell, Andrew
Flanagan, Dustin
Raven, Alexander
Hodder, Michael
Nasreddin, Nadia
Xue, Hai-Hui
Delorenzi, Mauro
Leedham, Simon
Petrova, Tatiana V.
Sansom, Owen
Alitalo, Kari
author_facet Heino, Sarika
Fang, Shentong
Lähde, Marianne
Högström, Jenny
Nassiri, Sina
Campbell, Andrew
Flanagan, Dustin
Raven, Alexander
Hodder, Michael
Nasreddin, Nadia
Xue, Hai-Hui
Delorenzi, Mauro
Leedham, Simon
Petrova, Tatiana V.
Sansom, Owen
Alitalo, Kari
author_sort Heino, Sarika
collection PubMed
description Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent tumors, but not in ligand-dependent, serrated tumors. To analyze Lef1 function in tumor development, we conditionally deleted Lef1 in intestinal stem cells of Apc(fl/fl) mice or broadly from the entire intestinal epithelium of Apc(fl/fl) or Apc(Min/+) mice. Loss of Lef1 markedly increased tumor initiation and tumor cell proliferation, reduced the expression of several Wnt antagonists, and increased Myc proto-oncogene expression and formation of ectopic crypts in Apc-mutant adenomas. Our results uncover a previously unknown negative feedback mechanism in CRC, in which ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches.
format Online
Article
Text
id pubmed-8598008
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-85980082021-11-29 Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas Heino, Sarika Fang, Shentong Lähde, Marianne Högström, Jenny Nassiri, Sina Campbell, Andrew Flanagan, Dustin Raven, Alexander Hodder, Michael Nasreddin, Nadia Xue, Hai-Hui Delorenzi, Mauro Leedham, Simon Petrova, Tatiana V. Sansom, Owen Alitalo, Kari Sci Adv Biomedicine and Life Sciences Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent tumors, but not in ligand-dependent, serrated tumors. To analyze Lef1 function in tumor development, we conditionally deleted Lef1 in intestinal stem cells of Apc(fl/fl) mice or broadly from the entire intestinal epithelium of Apc(fl/fl) or Apc(Min/+) mice. Loss of Lef1 markedly increased tumor initiation and tumor cell proliferation, reduced the expression of several Wnt antagonists, and increased Myc proto-oncogene expression and formation of ectopic crypts in Apc-mutant adenomas. Our results uncover a previously unknown negative feedback mechanism in CRC, in which ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches. American Association for the Advancement of Science 2021-11-17 /pmc/articles/PMC8598008/ /pubmed/34788095 http://dx.doi.org/10.1126/sciadv.abj0512 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Heino, Sarika
Fang, Shentong
Lähde, Marianne
Högström, Jenny
Nassiri, Sina
Campbell, Andrew
Flanagan, Dustin
Raven, Alexander
Hodder, Michael
Nasreddin, Nadia
Xue, Hai-Hui
Delorenzi, Mauro
Leedham, Simon
Petrova, Tatiana V.
Sansom, Owen
Alitalo, Kari
Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title_full Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title_fullStr Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title_full_unstemmed Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title_short Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
title_sort lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598008/
https://www.ncbi.nlm.nih.gov/pubmed/34788095
http://dx.doi.org/10.1126/sciadv.abj0512
work_keys_str_mv AT heinosarika lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT fangshentong lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT lahdemarianne lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT hogstromjenny lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT nassirisina lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT campbellandrew lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT flanagandustin lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT ravenalexander lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT hoddermichael lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT nasreddinnadia lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT xuehaihui lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT delorenzimauro lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT leedhamsimon lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT petrovatatianav lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT sansomowen lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas
AT alitalokari lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas